Cano Health Inc. [NYSE: CANO] stock went on an upward path that rose over 3.12% on Tuesday, amounting to a one-week price increase of more than 6.45%. The company report on February 27, 2023 that Cano Health Announces Closing of $150 Million Term Loan Facility with Diameter Capital Partners and Rubicon Founders.
From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio
The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.
Get our free report, "Top 5 AI Stocks to Buy for 2023".
Announces Preliminary Fourth Quarter 2022 Summary Financial Results.
Cano Health, Inc. (“Cano Health” or the “Company”) (NYSE: CANO), a leading value-based primary care provider and population health company, today announced that on February 24, 2023, it consummated the closing of a $150 million senior secured term loan (the “2023 Term Loan”), maturing November 23, 2027.
Over the last 12 months, CANO stock dropped by -68.21%. The one-year Cano Health Inc. stock forecast points to a potential upside of 60.53. The average equity rating for CANO stock is currently 2.70, trading closer to a bullish pattern in the stock market.
The market cap for the stock reached $826.37 million, with 232.31 million shares outstanding and 170.47 million shares in the current float. Compared to the average trading volume of 9.11M shares, CANO stock reached a trading volume of 17455584 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on Cano Health Inc. [CANO]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for CANO shares is $4.18 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on CANO stock is a recommendation set at 2.70. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
UBS have made an estimate for Cano Health Inc. shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on January 06, 2023. The new note on the price target was released on January 05, 2023, representing the official price target for Cano Health Inc. stock. Previously, the target price had yet another raise to $1.50, while BofA Securities analysts kept a Underperform rating on CANO stock.
The Average True Range (ATR) for Cano Health Inc. is set at 0.15, with the Price to Sales ratio for CANO stock in the period of the last 12 months amounting to 0.33. The Price to Book ratio for the last quarter was 0.94, with the Price to Cash per share for the same quarter was set at 0.05.
CANO Stock Performance Analysis:
Cano Health Inc. [CANO] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 6.45. With this latest performance, CANO shares gained by 30.95% in over the last four-week period, additionally sinking by -75.52% over the last 6 months – not to mention a drop of -68.21% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for CANO stock in for the last two-week period is set at 56.31, with the RSI for the last a single of trading hit 58.71, and the three-weeks RSI is set at 52.27 for Cano Health Inc. [CANO]. The present Moving Average for the last 50 days of trading for this stock 1.3700, while it was recorded at 1.5840 for the last single week of trading, and 4.2307 for the last 200 days.
Insight into Cano Health Inc. Fundamentals:
Operating Margin for any stock indicates how profitable investing would be, and Cano Health Inc. [CANO] shares currently have an operating margin of -5.89 and a Gross Margin at +9.29. Cano Health Inc.’s Net Margin is presently recorded at -1.12.
Return on Equity for this stock declined to -4.03, with Return on Assets sitting at -1.27.
Cano Health Inc.’s liquidity data is similarly interesting compelling, with a Current Ratio set at 1.60.
Cano Health Inc. [CANO] Insider Position Details
There are presently around $190 million, or 68.60% of CANO stock, in the hands of institutional investors. The top three institutional holders of CANO stocks are: JPMORGAN CHASE & CO with ownership of 16,374,893, which is approximately 3.074% of the company’s market cap and around 11.80% of the total institutional ownership; VANGUARD GROUP INC, holding 16,187,584 shares of the stock with an approximate value of $26.71 million in CANO stocks shares; and BLACKROCK INC., currently with $19.66 million in CANO stock with ownership of nearly -5.474% of the company’s market capitalization.
Positions in Cano Health Inc. stocks held by institutional investors increased at the end of Wednesday and at the time of the Wednesday reporting period, where 113 institutional holders increased their position in Cano Health Inc. [NYSE:CANO] by around 34,694,494 shares. Additionally, 101 investors decreased positions by around 83,859,192 shares, while 23 investors held positions by with 3,107,491 shares. The mentioned changes placed institutional holdings at 115,446,195 shares, according to the latest SEC report filing. CANO stock had 63 new institutional investments in for a total of 13,509,447 shares, while 50 institutional investors sold positions of 30,151,160 shares during the same period.